The present invention relates to caps for use in combination with fluid-holding vessels, such as those designed to receive and retain biological specimens for clinical analysis, patient monitoring or diagnosis. In particular, the present invention relates to a cap which is penetrable by a fluid transfer device used to transfer fluids to or from a fluid-holding vessel, where the vessel and cap remain physically and sealably associated during a fluid transfer.
All references referred to herein are hereby incorporated by reference in their entirety. The incorporation of these references, standing alone, should not be construed as an assertion or admission by the inventors that any portion of the contents of all of these references, or any particular reference, is considered to be essential material for satisfying any national or regional statutory disclosure requirement for patent applications. Notwithstanding, the inventors reserve the right to rely upon any of such references, where appropriate, for providing material deemed essential to the claimed invention by an examining authority or court. No reference referred to herein is admitted to be prior art to the claimed invention.
Collection devices are a type of cap and vessel combination commonly used for receiving and storing biological specimens for delivery to clinical laboratories, where the specimens may be analyzed to determine the existence or state of a particular condition or the presence of a particular infectious agent, such as a virus or bacterial microorganism. Types of biological specimens commonly collected and delivered to clinical laboratories for analysis include blood, urine, sputum, saliva, pus, mucous and cerebrospinal fluid. Since these specimen-types may contain pathogenic organisms, it is important to ensure that collection devices are constructed to be substantially leak-proof during transport from the site of collection to the site of analysis. This feature of collection devices is especially important when the clinical laboratory and the collection facility are remote from one another, increasing the likelihood that the collection device will be inverted or severely jostled during transport and potentially subjected to substantial temperature and pressure fluctuations.
To prevent specimen leakage, and possible contamination of the surrounding environment, collection device caps are typically designed to be screwed, snapped or otherwise frictionally fitted or welded onto the vessel component, thereby forming a substantially leak-proof seal between the cap and the vessel. In addition to preventing fluid specimen from leaking, a substantially leak-proof seal formed between the cap and the vessel components of a collection device may also aid in ameliorating exposure of the specimen to potentially contaminating influences from the immediate environment. This aspect of a leak-proof seal is important for preventing the introduction of contaminants into the collection device that could alter the qualitative or quantitative results of an assay.
While a leak-proof seal should prevent specimen seepage during transport, the actual removal of the cap from the vessel prior to specimen analysis presents another potential opportunity for contamination. When removing the cap, specimen which may have collected on the underside of the cap during transport could come into contact with a clinician, possibly exposing the clinician to a harmful pathogen present in the fluid sample. And if the specimen is proteinaceous or mucoid in nature, or if the transport medium contains detergents or surfactants, then a film or bubbles could form around the mouth of the vessel during transport which could burst when the cap is removed from the vessel, thereby disseminating specimen into the testing environment. Another risk associated with cap removal is the potential for creating a contaminating aerosol which may lead to false positives or exaggerated results in other specimens being simultaneously or subsequently assayed in the same general work area through cross-contamination. It is also possible that specimen residue from one collection device, which may have been inadvertently transferred to a gloved hand of a clinician, will come into contact with specimen from another collection device through routine or careless removal of caps and handling of the collection devices.
Concerns with cross-contamination are especially acute when the assay being performed involves nucleic acid detection and includes an amplification procedure such as the well known polymerase chain reaction (PCR), or a transcription-based amplification system such as transcription-mediated amplification (TMA). (A review of several amplification procedures currently in use, including PCR and TMA, is provided in H
To minimize the potential for creating contaminating specimen aerosols, and to limit direct contact between specimens and humans or the environment, it is desirable to have a collection device cap which can be penetrated by a fluid transfer device (e.g., a pipette tip which can be used with an air displacement pipette) while the cap remains physically and sealably associated with the vessel. The material and construction of the penetrable aspect of the cap should facilitate the venting of air displaced from the interior space of the collection device to ensure accurate fluid transfers and to prevent a rapid release of aerosols as the fluid transfer device is being inserted into or withdrawn from the collection device. And, because air is vented from the interior space of the collection device after the cap has been penetrated, it would be particularly helpful if means were included for minimizing aerosol release through the cap once it was penetrated by the fluid transfer device. Also, to limit the amount of potentially contaminating fluid present on the exterior of the fluid transfer device after it is has been withdrawn from the collection device, it would be advantageous if the cap also included means for wiping or absorbing fluid present on the outside of the fluid transfer device as it is being withdrawn from the collection device. To prevent damage to the fluid transfer device which could affect its ability to predictably and reliably dispense or draw fluids, and to facilitate its use in manual pipetting applications, the cap should also be designed to limit the forces necessary for the fluid transfer device to penetrate the cap. Ideally, the collection device could be used in both manual and automated formats and would be suitable for use with disposable pipette tips made of a plastic material.
Collection device caps which can be penetrated by a fluid transfer device will have other advantages, as well, including the time-savings resulting from clinicians not having to manually remove caps from vessels before retrieving sample aliquots from the collection devices for assaying. Another advantage of penetrable collection device caps would be the reduction in repetitive motion injuries suffered by clinicians from repeatedly unscrewing caps.
The present invention solves the potential contamination problems associated with conventional collection devices by providing a penetrable cap for use with a vessel component of a collection device which includes: (i) a closed side wall having an inner surface, an outer surface, a top surface and a bottom surface; (ii) attachment means for fixing the cap to an open end of the vessel in sealing engagement; (iii) a ledge which extends in a radial and inward direction from an inner surface of the side wall of the cap and has an end surface which defines an aperture sized to receive a fluid transfer device, where the inner surface of the side wall of the cap and a top surface of the ledge define a first bore; (iv) a frangible seal for preventing the passage of a fluid from an interior space of the vessel into the first bore when the cap is fixed to the vessel in sealing engagement, where the seal is affixed to either the top surface or a bottom surface of the ledge; (v) filtering means for impeding or preventing the release of an aerosol or bubbles from the interior space of the vessel to the atmosphere, where the filtering means is positioned substantially within the first bore; and (vi) retaining means for containing the filtering means within the first bore. (A “closed side wall” is one which lacks fully exposed end surfaces.) The retaining means is preferably affixed to a top wall of the cap. The side wall, the flange and the ledge of the cap are molded from a plastic material and preferably form a unitary piece.
In an alternative and preferred embodiment, the penetrable cap includes a skirt which depends from the bottom surface of the ledge, where an inner surface of the skirt defines a second bore having a diameter or width smaller than that of the first bore. The skirt may be included, inter alia, to further prevent a fluid from leaking from the interior of the vessel when the cap is fixed to the vessel in sealing engagement. (By “sealing engagement” is meant touching contact between solid surfaces which is intended to prevent or impede the passage of a fluid.) An outer surface of the skirt preferably includes a seal bead which is in frictional contact with an inner surface of the vessel. With this embodiment, the frangible seal may be affixed to either the top surface of the ledge or to a bottom surface of the skirt. The side wall, the flange, the ledge and the skirt of the cap of this embodiment are molded from a plastic material and preferably form a unitary piece.
In another embodiment of the present invention, the retaining means is a second frangible seal. The second frangible seal may comprise the same or a different material than the frangible seal affixed to the top or bottom surface of the ledge, or to the bottom surface of the skirt. Both seals are penetrable by a fluid transfer device with the application of moderate manual force and each seal preferably comprises a foil.
In still another embodiment of the present invention, the retaining means comprises a foil ring having a centrally located hole which is sized to receive a fluid transfer device and which is substantially axially aligned with the first bore and the second bore, if present. The diameter or width of this hole is smaller than the diameter or width of a filter contained within the first bore so that the foil ring can function to contain the filter within the cap. The foil ring of this embodiment may be affixed to the top wall of the cap by means of an adhesive or by means of a plastic liner which has been applied to the foil ring and which can be welded to the surface of the top wall of the cap.
In yet another embodiment of the present invention, the retaining means includes a plastic disc having a hole formed therein which is sized to receive a fluid transfer device and which is substantially axially aligned with the first bore and the second bore, if present. The retaining means of this embodiment functions to contain a filter within the first bore. The disc may be affixed to the top wall of the cap or the top wall may be adapted to include a seat for receiving the disc in, for example, a frictional or snap fit.
In a further embodiment, the retaining means comprises a removable seal which is designed to limit exposure of a filter to environmental contaminants and may include a tab for easy removal prior to penetrating the cap. Because this seal may be removed prior to penetration of the cap, it is not a requirement that this particular retaining means be comprised of a frangible material which can be pierced by a fluid transfer device applying moderate manual force. Since the removable seal can function to protect the filter against external contaminants during shipping, the removable seal may be applied, for example, to the fixed disc described above for retaining the filter within the first bore.
In still another embodiment, the cap is provided as part of a collection device which includes a vessel for containing fluids. When provided as a part of a collection device, the cap preferably includes the skirt feature described above, which is positioned adjacent to an inner surface of an open end of the vessel to impede the passage of a fluid from the interior space of the vessel to the environment outside of the collection device. Including a seal bead on an outer surface of the skirt further facilitates this objective by increasing the pressure which is exerted by the skirt on the inner surface of the vessel. The collection device may contain, for example, a dry powder, pellets of chemical reagents, buffers, stabilizers, or a transport medium for preserving a specimen while it is being shipped from a collection location to a site for analysis. The collection device may also be provided in packaged combination with a specimen retrieval device (e.g., a swab) for obtaining a specimen from a human, animal, water, environmental, industrial, food or other source. Instructional materials may additionally be included with the collection device which detail proper use of the collection device when obtaining or transporting a specimen or appropriate techniques for retrieving a fluid sample from the collection device at the site of analysis. When in packaged combination, the recited items are provided in the same container (e.g., a mail or delivery container for shipping), but do not need to be per se physically associated with one another in the container or combined in the same wrapper or vessel within the container.
In yet another embodiment, the cap can be used in a method for retrieving a fluid substance from the vessel component of a collection device with a plastic pipette tip for use with an air displacement pipette. When the cap is penetrated by the pipette tip, air passageways are formed between the pipette tip and the frangible seal or seals of the cap, thereby facilitating the venting of air from within the vessel. After fluid is removed from the collection device, at least some portion of the fluid sample may be exposed to amplification reagents and conditions permitting a targeted nucleic acid sequence which may be present in the fluid sample to be amplified. Various amplification procedures, and their associated reagents and conditions, are well known to those skilled in the art of nucleic acid diagnostics.
In still another embodiment, a method is provided for removing a fluid substance contained in a closed system comprising a cap and a fluid-holding vessel. In addition to the cap and vessel components, the phrase “closed system” is used herein to refer to a cap that is fixed to a vessel in sealing engagement to prevent the fluid contents of the system from escaping into the surrounding environment. The method includes penetrating first and second frangible seals affixed to the cap with a fluid transfer device, where the second seal is axially aligned below the first seal. Penetration of the first and second seals by the fluid transfer device results in the formation of air passageways between the seals and the fluid transfer device which aid in venting air from the interior space of the system. The fluid transfer device is preferably a plastic pipette tip for use with an air displacement pipette. In a preferred mode, the method further includes passing the fluid transfer device through a filter contained within the cap and interposed between the first and second seals.
Once fluid has been removed from the system in this method, some or all of the fluid sample may be exposed to amplification reagents and conditions permitting a targeted nucleic acid sequence which may be present in the fluid sample to be amplified. As noted above, a variety of amplification procedures are well known to those skilled in the art of nucleic acid diagnostics, and appropriate reagents and conditions for use with any of these amplification procedures could be determined without engaging in undue experimentation.
In yet a further embodiment of the present invention, a method is provided for depositing substances into the collection devices and other closed systems of the present invention by means of a substance transfer device capable of transporting fluids (e.g., specimen or assay reagents) or solids (e.g., particles, granules or powders). This embodiment of the present invention is particularly useful for diagnostic assays which can be performed in a single reaction vessel and where it is desirable to maintain the contents of the vessel in a substantially closed environment. The steps of this embodiment are similar to those of other preferred methods described herein, except that one or more substances would be deposited into the vessel component rather than retrieving a fluid sample contained therein.
The methods of the presently claimed invention may be performed manually or adapted for use with a semi-automated or fully automated instrument. Examples of instrument systems which could be readily adapted for use with the collection devices or other closed systems of the present invention include the DTS® 400 System (detection only) and the DTS® 1600 System (amplification and detection) (Gen-Probe Incorporated; San Diego, Calif.). See Acosta et al., “Assay Work Station,” U.S. Pat. No. 6,254,826. Other fully automated instrument systems are disclosed by Ammann et al., “Automated Process for Isolating and Amplifying a Target Nucleic Acid Sequence,” U.S. Pat. No. 6,335,166.
These and other features, aspects, and advantages of the present invention will become apparent to those skilled in the art after considering the following detailed description, appended claims and accompanying drawings.
While the present invention may be embodied in a variety of forms, the following description and accompanying drawings are merely intended to disclose some of these forms as specific examples of the present invention. Accordingly, the present invention is not intended to be limited to the forms or embodiments so described and illustrated. Instead, the full scope of the present invention is set forth in the appended claims.
With reference to the figures, preferred caps 30A-E of the present invention are shown alone or in combination with a vessel 20 which can be used for receiving and storing fluid specimens for subsequent analysis, including analysis with nucleic acid-based assays or immunoassays diagnostic for a particular pathogenic organism. When the desired specimen is a biological fluid, the specimen can be, for example, blood, urine, saliva, sputum, mucous or other bodily secretion, pus, amniotic fluid, cerebrospinal fluid or seminal fluid. However, the present invention also contemplates materials other than these specific biological fluids, including, but not limited to, water, chemicals and assay reagents, as well as solid substances which can be dissolved in whole or in part in a fluid milieu (e.g., tissue specimens, stool, environmental samples, food products, powders, particles and granules). The vessel 20 is preferably capable of forming a substantially leak-proof seal with the cap 30A-E and can be of any shape or composition, provided the vessel is shaped to receive and retain the material of interest (e.g., fluid specimen or assay reagents). Where the vessel 20 contains a specimen to be assayed, it is important that the composition of the vessel be essentially inert so that it does not significantly interfere with the performance or results of an assay. A preferred vessel 20 is formed of polypropylene and has a generally cylindrical shape which measures approximately 13 mm×82 mm.
As illustrated in the figures, particularly preferred caps 30A-E of the present invention include an integrally molded core structure 31A (referred to herein as the “core cap”) which comprises: (i) a generally cylindrical side wall 35; (ii) a flange 36 depending from a bottom surface 37 of the side wall and having an inner surface 38 adapted to grip an outer surface 21 of a generally cylindrical side wall 22 of an open-ended vessel 20; (iii) a ledge 39 extending radially inwardly from an inner surface 40 of the side wall 35 above the flange 36; and (iv) a generally cylindrical skirt 41 depending from a bottom surface 42 of the ledge in a substantially parallel orientation to the flange. The inner surface 40 of the side wall 35 and a top surface 43 of the ledge 39 define a first bore 44, as shown in
In an alternative core cap 31B embodiment shown in
While the ledge 39 of the core cap 31B shown in
A similar modification may be made to the preferred core cap 31A, whereby the inner surface 40 of the side wall 35 is extended radially inward until the inner surface 45 of the skirt 41 is co-extensive with the inner surface of the side wall. This modified form of the core cap 31A (not shown) eliminates the ledge 39, transforms the first and second bores 44, 46 into a single bore, and requires that the frangible seal 32 be affixed to the bottom surface 47 of the skirt 41. The disadvantage of these modified forms of the core caps 31A, 31B is that the alteration or elimination of the ledge 39 makes it is more difficult to maintain the filter 33 within the cap 30A-E when the cap is penetrated by a fluid transfer device. This problem may be overcome by adhering the filter 33 to the side wall 35 of the cap 30A-E, the frangible seal 32 or the retaining means 34A-C, for example.
The core cap 31A-B may be integrally molded from a number of different polymer and heteropolymer resins, including, but not limited to, polyolefins (e.g., high density polyethylene (“HDPE”), low density polyethylene (“LDPE”), a mixture of HDPE and LDPE, or polypropylene), polystyrene, high impact polystyrene and polycarbonate. A currently preferred material for forming the core cap 31A-B is an HDPE material sold under the tradename Alathon M5370 by GE Polymerland of Huntersville, N.C. Skilled artisans will readily appreciate that the range of acceptable cap resins will, in part, depend upon the nature of the resin used to form the vessel, since the properties of the resins used to form these two components will affect how well the cap 30A-E and vessel 20 components of a collection device 10 can form a leak proof seal and the ease with which the cap can be securely screwed onto the vessel. As with the vessel 20 component, the material of the core cap 31A-B should be essentially inert with respect to a fluid substance (including assay reagents) contained in the collection device 10 so that the material of the core cap does not significantly interfere with the performance or results of an assay.
The core cap 31A-B is injection molded as a unitary piece using procedures well-known to those skilled in the art of injection molding. After the core cap 31A-B has been formed and cured for a sufficient period of time, the following components are added to the core cap in the indicated manner and in any practicable order: (i) the frangible seal 32 to the top surface 43 of the ledge 39 of either core cap 31A-B, to the bottom surface 42 of the ledge of the alternative core cap 31B, or to the bottom surface 47 of the skirt 41 of the preferred core cap 31A; (ii) a filter 33 within the first bore 44; and (iii) a retainer 34A-D to the annular top wall 48.
The frangible seal 32 is included to provide a substantially leak-proof barrier between the fluid contents of a collection device 10 and the filter 33 contained in the first bore 44. For this reason, it is not critical whether the frangible seal 32 is affixed to a surface 42, 43 of the ledge 39 or to the bottom surface 47 of the skirt 41. According to a preferred embodiment of the present invention, the width of the annular top surface 43 of the ledge 39 is about 0.08 inches (2.03 mm), the thickness of the ledge (the distance between the top and bottom surfaces 43, 42 of the ledge) is about 0.038 inches (0.97 mm), the combined width of the annular bottom surface 42 of the ledge and the exposed bottom surface 37 of the side wall 35 is about 0.115 inches (2.92 mm), and the width of the annular bottom surface 47 of the skirt 41 is about 0.025 inches (0.635 mm). The dimensions of these features of the core cap 31A-B may vary, of course, provided sufficient surface area exists for affixing the frangible seal 32 to the core cap in a substantially leak-proof manner.
The frangible seal 32 may be made of a plastic film (e.g., thin monoaxially or biaxially oriented plastic film) or, preferably, of a foil (e.g., aluminum foil or other foil exhibiting low water vapor transmission), which can be affixed to a surface 42, 43 of the ledge 39 or to the bottom surface 47 of the skirt 41 by means well known to those skilled in the art, including adhesives. The frangible seal 32 is preferably not an integral component of the core cap 31A-B. If the frangible seal 32 comprises a foil, it may further include a compatibilizer, such as a thin veneer of plastic applied to one or both surfaces of the foil, which will promote a substantially leak-proof attachment of the frangible seal to a surface of the core cap 31A-B with the application of thermal energy. A heat sealer or heat induction sealer may be used to generate the requisite thermal energy. (To avoid the potentially deleterious effects of corrosion, it is recommended that all portions of a metallic frangible seal 32 which might become exposed to the fluid contents of a collection device 10 during routine handling be coated with a plastic liner.) A TOSS Machine heat sealer (Packworld USA; Nazareth, Pa.; Model No. RS242) is preferred for attaching the frangible seal 32 to a surface 42, 43 of the ledge 39 or to the bottom surface 47 of the skirt 41. Ultrasonic and radio frequency welding procedures known to those skilled in the art may also be used to affix the frangible seal 32 to the core cap 31A-B.
To further promote attachment of the frangible seal 32 to the core cap 31A-B, a surface 42, 43 of the ledge 39 or the bottom surface 47 of the skirt 41 may be modified during injection molding of the core cap to include an energy director, such as an annular ring or series of protuberances. By limiting contact between the frangible seal 32 and a plastic surface of the ledge 39 or skirt 41, an energy director allows the frangible seal 32 to be affixed to the ledge or skirt in less time and using less energy than would be required in its absence when an ultrasonic welding procedure is followed. This is because the smaller surface area of the protruding energy director melts and forms a weld with the plastic material of the frangible seal 32 more quickly than is possible with a flat, unmodified plastic surface. An energy director of the present invention is preferably a continuous surface ring which is triangular in cross-section.
In order to facilitate the venting of air from within a collection device 10, the frangible seal 32 is preferably constructed so that it tears when the seal is penetrated by a fluid transfer device, thereby forming air passageways 70 between the seal and the fluid transfer device, as described in detail infra. To achieve this tearing, the seal 32 preferably includes a brittle layer comprised of a hard plastic material, such as a polyester. (See C
An alternative frangible seal 32 embodiment is depicted in
As illustrated in the figures, the filter 33 is positioned within the first bore 44 above the ledge 39 and is incorporated to retard or block the movement of an escaping aerosol or bubbles after the seal has been pierced by a fluid transfer device. The filter 33 can also be constructed to perform a wiping action on the outside of a fluid transfer device as the fluid transfer device is being removed from a collection device 10. In a preferred mode, the filter 33 functions to draw fluids away from the outside of a fluid transfer device by means of capillary action. As used herein, however, the term “filter” refers generally to a material which performs a wiping function to remove fluids present on the outside of a fluid transfer device and/or an absorbing function to hold or otherwise sequester fluids removed from the outside of a fluid transfer device. For reasons discussed below, the filters 33 of the present invention are composed of a material or combination of materials having pores or interstices which admit the passage of a gas. Examples of filter 33 materials which may be used with the cap 30A-E of the present invention include, but are not limited to, pile fabrics, sponges, foams (with or without a surface skin), felts, sliver knits, a GORE-TEX® fabric, a fabric containing a LYCRA® fiber, and other materials and blends, both natural and synthetic. These materials may also be mechanically or chemically treated to further improve the intended functions of the filter 33. For example, napping may be used to increase the surface area and, therefore, the fluid holding capacity of a filter 33. The material of the filter 33 may also be pre-treated with a wetting agent, such as a surfactant, to lower the surface tension of a fluid present on an outer surface of a fluid transfer device. An acrylic binder might be used, for example, to actually bind the wetting agent to the filter 33 material. Additionally, the filter 33 may include a super-absorbent polymer, (see, e.g., Sackmann et al., “Pre-Formed Super Absorbers with High Swelling Capacity,” U.S. Pat. No. 6,156,848), to prevent a fluid from escaping from a penetrated collection device 10.
To limit the unobstructed passage of air from within a collection device 10 to the environment, the filter 33 is preferably made of a resilient material whose original shape is restored, or substantially restored, as a fluid transfer device is being removed from the collection device. This characteristic of the filter 33 is especially important when the fluid transfer device has a non-uniform diameter, as is the case with most pipette tips used with standard air displacement pipettes. Thus, materials such as pile fabric, sponges, foams, and fabrics containing LYCRA® fibers are preferred because they tend to quickly restore their original shape after exposure to compressive forces. Pile fabric is a particularly preferred filter 33. An example of a preferred pile fabric is an acrylic material having a thickness of about 0.375 inches (9.53 mm) which is available from Roller Fabrics of Milwaukee, Wis. as Part No. ASW112. Examples of other acceptable pile fabrics include those made of acrylic and polyester materials and which range in size from about 0.25 inches (6.35 mm) to about 0.3125 inches (7.94 mm). Such pile fabrics are available from Mount Vernon Mills, Inc. of LaFrance, S.C. as Part Nos. 0446, 0439 and 0433. The filter 33 material is preferably inert with respect to a fluid substance contained within the vessel 20.
Because the filter 33 is intended to remove fluid from the exterior of a fluid transfer device and to capture fluid in the form of an aerosol or bubbles, it is best if the material and dimensions of the filter material are chosen so that the filter does not become saturated with fluid during use. If the filter 33 does become saturated, fluid may not be adequately wiped from the exterior of the fluid transfer device and bubbles may be produced as the fluid transfer device passes through the filter or as air is displaced from within the collection device 10. Thus, it is important to adapt the size and adsorptive properties of the filter 33 in order to achieve adequate wiping and aerosol or bubble containment. Considerations when selecting a filter 33 will include the cap configuration, the shape and size of the fluid transfer device and the nature and amount of fluid substance contained in the vessel 20, especially in view of the number of anticipated fluid transfers for a given collection device 10. As the amount of fluid a filter 33 is likely to be exposed to increases, the volume of the filter material or its absorptive properties may need to be adjusted so that the filter does not become saturated during use.
It is also important that the filter 33 be constructed and arranged in the cap 30A-E so that the flow of air out of the collection device 10 remains relatively unimpeded as the cap is being penetrated by a fluid transfer device. In other words, the material of the filter 33 and its arrangement within the cap 30A-E should facilitate the venting of air displaced from within the collection device 10. Of course, this venting property of the filter 33 needs to be balanced with the requirement that the filter material have sufficient density to trap an escaping aerosol or bubbles. Consequently, those skilled in the art will appreciate the need to select or design filter 33 materials having matrices that are capable of trapping an aerosol or bubbles, while simultaneously permitting air to be vented from within the collection device 10 once the underlying seal 32 has been pierced by a fluid transfer device.
As the figures show, the filter 33 is preferably sized to fit within the first bore 44 beneath the horizontal plane of the annular top wall 48. In a preferred cap 30A-E of the present invention, the filter 33 also rests substantially or completely above the ledge 39, even though the seal 32 may be affixed to the bottom surface 47 of the skirt 41, as illustrated in
The material and configuration of the filter 33 should be such that it creates minimal frictional interference with a fluid transfer device as it is being inserted into or withdrawn from the collection device 10. In the case of a sponge or foam, for example, this may require boring a hole or creating one or more slits in the center of the filter 33 (not shown) which are sized to minimize frictional interference between the filter and a fluid transfer device, while at the same time providing enough interference so that aerosol or bubble transmission is limited and the wiping action is performed by the filter material. If a pile fabric is employed as the filter 33, the pile fabric is preferably arranged in the manner shown in
To immobilize the filter 33 within the first bore 44, the caps 30A-E of the present invention include a retainer 34A-D positioned above the filter, preferably on the annular top wall 48. In a preferred embodiment shown in
As illustrated in
Besides providing a means for keeping the filter 33 fixed within the first bore 44 prior to and during a fluid transfer, a seal retainer 34A can protect the underlying filter from external contaminants prior to penetration of the cap 30A. Moreover, a cap 30A designed to completely seal the filter 33 within the first bore 44 may be sterilized prior to use by, for example, gamma irradiation. Additionally, the retainer 34 of such a cap 30A could be wiped with a disinfectant or the entire collection device 10 could be irradiated with ultraviolet light prior to penetration to facilitate a sterile fluid transfer.
In those instances where the potential presence of contaminants on the filter would not be of significant concern, however, the retainer may comprise a foil ring, for example, which includes a centrally located hole which is sized to receive a fluid transfer device. As illustrated in
Another cap 30D embodiment is illustrated in
When a cap 30A-E of the present invention is pierced by a fluid transfer device 90 which is used to retrieve at least a portion of a fluid sample 100 contained in a collection device 10, as shown in
The insertion force, which is the total or additive force required to pierce all penetrable surfaces of a cap 30A-E according to the present invention (i.e., the frangible seal 32, the filter 33 and, optionally, the retainer 34A) with a fluid transfer device, is preferably less than about 8 pounds force (35.59 N), more preferably less than about 6.5 pounds force (28.91 N), even more preferably less than about 5 pounds force (22.24 N), and most preferably less than about 4.5 pounds force (20.02 N). The withdrawal force, which is the force required to completely withdraw a fluid transfer device from the collection device 10 after the cap 30A-E has been completely penetrated, is preferably less than about 4 pounds force (17.79 N), more preferably less than about 3 pounds force (13.34 N), even more preferably less than about 2 pounds force (8.90 N), and most preferably less than about 1 pound force (4.45 N). The forces exerted on the fluid transfer device as it is being withdrawn from a collection device 10 should be minimized to avoid stripping the fluid transfer device from, for example, the mounting probe of a vacuum pipette. Insertion and withdrawal forces can be determined using conventional force measurement instruments, such as a motorized test stand (Model No. TCD 200) and digital force gauge (Model No. DFGS-50) available from John Chatillon & Sons, Inc. of Greensboro, N.C.
A cap 30A-E according to the present invention is generally provided in combination with a fluid-holding vessel 20 as components of a collection device 10. The cap 30A-E and vessel 20 of the collection device 10 can be joined by means of mated threads which allow the cap to be screwed, snapped or otherwise frictionally fitted onto an outer surface 21 of the side wall 22 at the open end of the vessel. When the cap 30A-E is frictionally fitted onto the vessel 20, the bottom surface 37 of the side wall 35 of the cap is preferably in contact with the annular top surface 23 of the vessel to provide an interference fit, thereby facilitating the essentially leak-proof seal discussed above. The cap 30A-E can be modified to further improve resistance of the collection device 10 to leaking by providing an annular seal bead 58 to an outer surface 59 of the skirt 41, as shown in
When provided as a component of a kit, the collection device 10 of the present invention preferably includes a specimen retrieval device for obtaining a sample to be analyzed, where the specimen retrieval device has preferably been sized to fit within the interior space 11 of the collection device after the cap 30A-E and vessel 20 have been joined. A preferred specimen retrieval device is a swab, such as the swab disclosed by Pestes et al., “Cell Collection Swab,” U.S. Pat. No. 5,623,942. This particular swab is preferred because it is manufactured to include a score line which is positioned on the stem of the swab, allowing the swab to be manually snapped in two after a specimen has been obtained, leaving the lower, specimen-bearing portion of the swab entirely inside the vessel 20 component of the collection device 10. When the specimen is being transported to a clinical laboratory, the collection device 10 also preferably includes a transport medium for preserving the sample prior to analysis. Transport mediums are well known in the art and will vary depending upon the sample type and whether cell lysis prior to analysis is necessary.
Additionally, a kit according to the present invention may include instructions recorded in a tangible form (e.g., contained on paper or an electronic medium) which explain how the components of the collection device 10 are to be manipulated when obtaining a fluid sample or how the cap 30A-E is to be secured onto the vessel 20 prior to transporting the collection device to a clinical laboratory. Alternatively, or in addition to, the instructions may detail proper pipetting techniques for retrieving at least a portion of the sample from the collection device 10 prior to analysis. These instructions may include information about types of fluid transfer devices that can be used to penetrate the cap 30A-E, positioning of a fluid transfer device for penetrating the cap and/or the amount of force needed to penetrate the cap. The instructional materials may also detail proper use of the collection device when the sample is to be exposed to reagents and conditions useful for amplifying a nucleic acid sequence targeted for detection.
Amplification prior to detection is particularly desirable in diagnostic assays where the initial population of targeted nucleic acid sequences in a sample is expected to be relatively small, making detection of the targeted nucleic acid sequences more difficult. There are many procedures for amplifying nucleic acids which are well known in the art, including, but not limited to, the polymerase chain reaction (PCR), (see, e.g., Mullis, “Process for Amplifying, Detecting, and/or Cloning Nucleic Acid Sequences,” U.S. Pat. No. 4,683,195), transcription-mediated amplification (TMA), (see, e.g., Kacian et al., “Nucleic Acid Sequence Amplification Methods,” U.S. Pat. No. 5,399,491), ligase chain reaction (LCR), (see, e.g., Birkenmeyer, “Amplification of Target Nucleic Acids Using Gap Filling Ligase Chain Reaction,” U.S. Pat. No. 5,427,930), and strand displacement amplification (SDA), (see, e.g., Walker, “Strand Displacement Amplification,” U.S. Pat. No. 5,455,166). The particular reagents (e.g., enzymes and primers) and conditions selected by practitioners will vary depending upon the particular nucleic acid sequence being targeted for detection and the specific amplification procedure to be followed. Those skilled in the art of nucleic acid diagnostics, however, will be able to select appropriate reagents and conditions for amplifying a specific targeted nucleic acid sequence following a particular amplification procedure without having to engage in undue experimentation.
While the present invention has been described and shown in considerable detail with reference to certain preferred embodiments, those skilled in the art will readily appreciate other embodiments of the present invention. Accordingly, the present invention is deemed to include all modifications and variations encompassed within the spirit and scope of the following appended claims.
This application is a reissue of U.S. Pat. No. 8,057,762, which is a continuation of U.S. application Ser. No. 12/753,010, filed Apr. 1, 2010, now pendingU.S. Pat. No. 8,052,944, which is a continuation of U.S. application Ser. No. 11/869,233, filed Oct. 9, 2007, now U.S. Pat. No. 7,691,332, which is a continuation of U.S. application Ser. No. 10/954,578, filed Sep. 29, 2004, now U.S. Pat. No. 7,294,308, which is a divisional of U.S. application Ser. No. 10/093,511, filed Mar. 8, 2002, now U.S. Pat. No. 6,893,612, which claims the benefit of U.S. Provisional Application No. 60/274,493, filed Mar. 9, 2001, each of which applications is hereby incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
651460 | Higgins | Jun 1900 | A |
1080891 | Carson | Dec 1913 | A |
1108645 | Weissenthanner | Aug 1914 | A |
1184568 | Puhl | May 1916 | A |
1413703 | Biehn | Apr 1922 | A |
1431871 | Burnet | Oct 1922 | A |
1509916 | Waite | Sep 1924 | A |
1702182 | Van Vlijmen | Feb 1929 | A |
2099370 | Monnier | Nov 1937 | A |
2163367 | Barnes | Jun 1939 | A |
2186888 | Tullar et al. | Jan 1940 | A |
2200600 | Grapp | May 1940 | A |
2240101 | Smith | Apr 1941 | A |
2906423 | Sandhage | Sep 1959 | A |
3088615 | Mumford et al. | May 1963 | A |
3146904 | Hansen et al. | Sep 1964 | A |
3194424 | Barr | Jul 1965 | A |
3392859 | Fischer | Jul 1968 | A |
3439824 | Merrill, Jr. et al. | Apr 1969 | A |
3460702 | Andrews | Aug 1969 | A |
3495993 | Barr et al. | Feb 1970 | A |
3496993 | Barr et al. | Feb 1970 | A |
3519157 | Meierhoefer | Jul 1970 | A |
3552591 | Wimmer | Jan 1971 | A |
3578037 | Flynn | May 1971 | A |
3593909 | Bergmann | Jul 1971 | A |
3607098 | Strande | Sep 1971 | A |
3676076 | Grady | Jul 1972 | A |
3720343 | Irish, Jr. | Mar 1973 | A |
3938686 | Milligan et al. | Feb 1976 | A |
4053084 | Anderson | Oct 1977 | A |
4072233 | Kramer et al. | Feb 1978 | A |
4103772 | Wiegner | Aug 1978 | A |
4105133 | La Barge et al. | Aug 1978 | A |
4134512 | Nugent | Jan 1979 | A |
4146148 | Dwinell et al. | Mar 1979 | A |
4152269 | Babson | May 1979 | A |
4171236 | Winchell et al. | Oct 1979 | A |
4178976 | Weiler et al. | Dec 1979 | A |
4193698 | Gartner | Mar 1980 | A |
4209126 | Elias | Jun 1980 | A |
4217327 | Cancio et al. | Aug 1980 | A |
4222974 | Smith | Sep 1980 | A |
4226333 | Percarpio | Oct 1980 | A |
4234103 | Strobl, Jr. et al. | Nov 1980 | A |
4236646 | Ganz, Jr. et al. | Dec 1980 | A |
4243150 | Gunne et al. | Jan 1981 | A |
4247001 | Wiegner | Jan 1981 | A |
4248355 | Kolb et al. | Feb 1981 | A |
4254884 | Maruyama | Mar 1981 | A |
4261474 | Cohen | Apr 1981 | A |
4265242 | Cohen | May 1981 | A |
4266687 | Cummings | May 1981 | A |
4278437 | Haggar | Jul 1981 | A |
4301936 | Percarpio | Nov 1981 | A |
4304869 | Dyke | Dec 1981 | A |
4412623 | Schmidt | Nov 1983 | A |
4418827 | Butterfield | Dec 1983 | A |
4465200 | Percarpio | Aug 1984 | A |
4515752 | Miramanda | May 1985 | A |
4519513 | Weiler et al. | May 1985 | A |
4524809 | Dent | Jun 1985 | A |
4531649 | Shull | Jul 1985 | A |
4539855 | Jacobs | Sep 1985 | A |
4545497 | Martha, Jr. | Oct 1985 | A |
4562859 | Shames et al. | Jan 1986 | A |
4576297 | Larson | Mar 1986 | A |
4582207 | Howard et al. | Apr 1986 | A |
4600112 | Shillington et al. | Jul 1986 | A |
4640424 | White | Feb 1987 | A |
4652429 | Konrad | Mar 1987 | A |
4655763 | Malcolm et al. | Apr 1987 | A |
4664274 | Konrad | May 1987 | A |
4682703 | Kasai et al. | Jul 1987 | A |
4685917 | Baldini et al. | Aug 1987 | A |
4693834 | Hossom | Sep 1987 | A |
4697717 | Grippi | Oct 1987 | A |
4703865 | Bates | Nov 1987 | A |
4706827 | Cabernoch et al. | Nov 1987 | A |
4722449 | Dubach | Feb 1988 | A |
4732850 | Brown et al. | Mar 1988 | A |
4747500 | Gach et al. | May 1988 | A |
4789639 | Fleming | Dec 1988 | A |
4795043 | Odet et al. | Jan 1989 | A |
4803998 | Kezes et al. | Feb 1989 | A |
4808381 | McGregor et al. | Feb 1989 | A |
4811856 | Fischman | Mar 1989 | A |
4815618 | Gach | Mar 1989 | A |
4815619 | Turner et al. | Mar 1989 | A |
4817807 | Hummer | Apr 1989 | A |
4849173 | Chang | Jul 1989 | A |
4863051 | Eibner et al. | Sep 1989 | A |
4863453 | Berger et al. | Sep 1989 | A |
4873193 | Jensen et al. | Oct 1989 | A |
4886177 | Foster | Dec 1989 | A |
4892222 | Schmidt et al. | Jan 1990 | A |
4898293 | Morel | Feb 1990 | A |
4920976 | Calzi et al. | May 1990 | A |
4948009 | Sawatani | Aug 1990 | A |
4957637 | Cornell | Sep 1990 | A |
4961986 | Galda et al. | Oct 1990 | A |
4981464 | Suzuki | Jan 1991 | A |
4995521 | Von Schuckmann | Feb 1991 | A |
D315680 | Baxter | Mar 1991 | S |
4999163 | Lennon et al. | Mar 1991 | A |
5016770 | Rizzardi | May 1991 | A |
5024327 | Shillington | Jun 1991 | A |
5036992 | Mouchawar et al. | Aug 1991 | A |
5053134 | Luderer et al. | Oct 1991 | A |
5057365 | Finkelstein et al. | Oct 1991 | A |
5061263 | Yamazaki et al. | Oct 1991 | A |
5065768 | Coleman et al. | Nov 1991 | A |
5070884 | Columbus et al. | Dec 1991 | A |
5071017 | StulI | Dec 1991 | A |
5078968 | Nason | Jan 1992 | A |
5084393 | Rogalsky | Jan 1992 | A |
5088996 | Kopfer et al. | Feb 1992 | A |
5100010 | Waters | Mar 1992 | A |
5102010 | Osgar et al. | Apr 1992 | A |
5111946 | Glanz | May 1992 | A |
5130254 | Collier et al. | Jul 1992 | A |
5165560 | Ennis, III et al. | Nov 1992 | A |
5169602 | Pang et al. | Dec 1992 | A |
5188620 | Jepson et al. | Feb 1993 | A |
5188628 | Rani et al. | Feb 1993 | A |
5201459 | Bettle, Jr. et al. | Apr 1993 | A |
5202093 | Cloyd | Apr 1993 | A |
5234001 | Goldstein et al. | Aug 1993 | A |
5275299 | Konrad et al. | Jan 1994 | A |
5279606 | Haber et al. | Jan 1994 | A |
5294011 | Konrad et al. | Mar 1994 | A |
5295599 | Smith | Mar 1994 | A |
5297599 | Bucheli | Mar 1994 | A |
5303838 | Luch et al. | Apr 1994 | A |
5306054 | Georgopoulos | Apr 1994 | A |
5306270 | Macartney et al. | Apr 1994 | A |
5308506 | McEwen et al. | May 1994 | A |
5326534 | Yamazaki et al. | Jul 1994 | A |
5328041 | Hook et al. | Jul 1994 | A |
5358690 | Guirguis | Oct 1994 | A |
5370252 | Parsons et al. | Dec 1994 | A |
5395365 | Weiler et al. | Mar 1995 | A |
5397023 | Toczek et al. | Mar 1995 | A |
D357985 | Burns | May 1995 | S |
5429619 | Furnish | Jul 1995 | A |
5433330 | Yatsko et al. | Jul 1995 | A |
5433716 | Leopardi et al. | Jul 1995 | A |
5471706 | Wallock et al. | Dec 1995 | A |
5494170 | Burns | Feb 1996 | A |
5501676 | Niedospial et al. | Mar 1996 | A |
5505326 | Junko | Apr 1996 | A |
5514339 | Leopardi et al. | May 1996 | A |
5522518 | Konrad et al. | Jun 1996 | A |
5525304 | Matsson et al. | Jun 1996 | A |
5540674 | Karas et al. | Jul 1996 | A |
5540890 | Clark et al. | Jul 1996 | A |
5566859 | Willis et al. | Oct 1996 | A |
5588547 | Derksen | Dec 1996 | A |
5595907 | Kayal et al. | Jan 1997 | A |
5604101 | Hanley et al. | Feb 1997 | A |
5611792 | Gustafsson et al. | Mar 1997 | A |
5623942 | Pestes et al. | Apr 1997 | A |
5627071 | Triva et al. | May 1997 | A |
5632396 | Burns | May 1997 | A |
5637099 | Durdin et al. | Jun 1997 | A |
5658531 | Cope et al. | Aug 1997 | A |
5681742 | MersKelly et al. | Oct 1997 | A |
5707823 | Carr et al. | Jan 1998 | A |
5738233 | Burns | Apr 1998 | A |
5738920 | Knors | Apr 1998 | A |
5753186 | Hanley et al. | May 1998 | A |
5779074 | Burns | Jul 1998 | A |
5786227 | Charlton | Jul 1998 | A |
5874048 | Seto et al. | Feb 1999 | A |
5876926 | Beecham | Mar 1999 | A |
5895631 | Tajima | Apr 1999 | A |
5915577 | Levine | Jun 1999 | A |
5924584 | Hellstrom et al. | Jul 1999 | A |
5932482 | Markelov | Aug 1999 | A |
5935523 | McCandless et al. | Aug 1999 | A |
5945070 | Kath et al. | Aug 1999 | A |
5954214 | Guezennec et al. | Sep 1999 | A |
5957822 | Bienhaus et al. | Sep 1999 | A |
5958778 | Kidd | Sep 1999 | A |
5989499 | Catanzariti et al. | Nov 1999 | A |
5992660 | Miura et al. | Nov 1999 | A |
6001087 | Zurcher | Dec 1999 | A |
6006931 | Sarstedt | Dec 1999 | A |
6024235 | Schwab | Feb 2000 | A |
6030582 | Levy | Feb 2000 | A |
6054099 | Levy | Apr 2000 | A |
6056135 | Widman | May 2000 | A |
6068150 | Mitchell et al. | May 2000 | A |
6126903 | Preston et al. | Oct 2000 | A |
6145688 | Smith | Nov 2000 | A |
6170693 | Goto | Jan 2001 | B1 |
6234335 | Gee et al. | May 2001 | B1 |
6255101 | Rousseau et al. | Jul 2001 | B1 |
6274087 | Preston et al. | Aug 2001 | B1 |
6277331 | Konrad | Aug 2001 | B1 |
6286698 | Hague et al. | Sep 2001 | B2 |
6315145 | Fask et al. | Nov 2001 | B1 |
6361744 | Levy | Mar 2002 | B1 |
6375022 | Zurcher et al. | Apr 2002 | B1 |
D457247 | Iheme et al. | May 2002 | S |
6402407 | Goldstein | Jun 2002 | B1 |
6406671 | DiCesare et al. | Jun 2002 | B1 |
6426046 | Cassells et al. | Jul 2002 | B1 |
6464105 | Rolle et al. | Oct 2002 | B1 |
6475774 | Gupta | Nov 2002 | B1 |
6500390 | Boulton et al. | Dec 2002 | B1 |
6517782 | Horner et al. | Feb 2003 | B1 |
6517783 | Horner et al. | Feb 2003 | B2 |
6562300 | Rosen et al. | May 2003 | B2 |
6602474 | Tajima | Aug 2003 | B1 |
6607685 | Naritomi et al. | Aug 2003 | B2 |
6617170 | Augello et al. | Sep 2003 | B2 |
6627156 | Goodale et al. | Sep 2003 | B1 |
6662957 | Zurcher et al. | Dec 2003 | B2 |
6716396 | Anderson et al. | Apr 2004 | B1 |
6723289 | Iheme et al. | Apr 2004 | B2 |
6752965 | Levy | Jun 2004 | B2 |
6806094 | Anderson et al. | Oct 2004 | B2 |
6837954 | Carano | Jan 2005 | B2 |
6893612 | Kacian et al. | May 2005 | B2 |
6943035 | Davies et al. | Sep 2005 | B1 |
6959615 | Gamble | Nov 2005 | B2 |
6994699 | Houwaert et al. | Feb 2006 | B2 |
7097057 | Classens | Aug 2006 | B2 |
7128228 | Collins | Oct 2006 | B2 |
7153477 | DiCesare et al. | Dec 2006 | B2 |
7188734 | Konrad | Mar 2007 | B2 |
7276208 | Sevigny et al. | Oct 2007 | B2 |
7276383 | Iheme et al. | Oct 2007 | B2 |
7282182 | Dale et al. | Oct 2007 | B2 |
7285423 | Ulin | Oct 2007 | B2 |
7294308 | Kacian | Nov 2007 | B2 |
7309468 | Stevens et al. | Dec 2007 | B2 |
7309469 | Anderson et al. | Dec 2007 | B2 |
7387216 | Smith | Jun 2008 | B1 |
7435389 | Anderson et al. | Oct 2008 | B2 |
7578975 | DiCesare et al. | Aug 2009 | B2 |
7691332 | Kacian et al. | Apr 2010 | B2 |
7824922 | Kacian et al. | Nov 2010 | B2 |
8052944 | Kacian et al. | Nov 2011 | B2 |
8685347 | Kacian et al. | Apr 2014 | B2 |
20010039058 | Iheme et al. | Nov 2001 | A1 |
20010041336 | Anderson et al. | Nov 2001 | A1 |
20020029022 | Naritomi et al. | Mar 2002 | A1 |
20020131902 | Levy | Sep 2002 | A1 |
20020132367 | Miller et al. | Sep 2002 | A1 |
20030052074 | Chang et al. | Mar 2003 | A1 |
20030053938 | Szeles | Mar 2003 | A1 |
20040067169 | Krause | Apr 2004 | A1 |
20040076546 | Bissett | Apr 2004 | A1 |
20040091401 | Golabek et al. | May 2004 | A1 |
20040152205 | Anderson et al. | Aug 2004 | A1 |
20050059161 | Anderson et al. | Mar 2005 | A1 |
20050281713 | Hampsch et al. | Dec 2005 | A1 |
20060057738 | Hall | Mar 2006 | A1 |
20080072690 | Kacian et al. | Mar 2008 | A1 |
20090098567 | Kacian et al. | Apr 2009 | A1 |
20090208966 | Kacian et al. | Aug 2009 | A1 |
20100019021 | Dixon-Garrett et al. | Jan 2010 | A1 |
20100190215 | Kacian et al. | Jul 2010 | A1 |
20130160574 | Kacian et al. | Jun 2013 | A1 |
Number | Date | Country |
---|---|---|
1 209 004 | Aug 1986 | CA |
37 33 696 | Mar 1989 | DE |
199 38 078 | Feb 2001 | DE |
0 081 976 | Jun 1983 | EP |
0 115 480 | Aug 1984 | EP |
0 330 883 | Sep 1989 | EP |
0454493 | Oct 1991 | EP |
0513901 | Nov 1992 | EP |
1 468 801 | Mar 1977 | GB |
2 048 836 | Dec 1980 | GB |
7051253 | Feb 1995 | JP |
2594337 | May 1995 | JP |
8103433 | Apr 1996 | JP |
9945360 | Sep 1999 | WO |
0069389 | Nov 2000 | WO |
WO0069389 | Nov 2000 | WO |
Entry |
---|
USPTO Office Action, U.S. Appl. No. 10/093,511, Oct. 27, 2004. |
USPTO Notice of Allowance, U.S. Appl. No. 10/093,511, Jan. 31, 2005. |
USPTO Office Action, U.S. Appl. No. 10/954,578, Apr. 4, 2007. |
USPTO Notice of Allowance, U.S. Appl. No. 10/954,578, Oct. 2, 2007. |
PCT Search Report, International Application No. PCT/US02/07266, Jul. 16, 2002. |
APO Office Action, Australian Patent Application No. 2009200876, Jun. 3, 2009. |
APO Office Action, Australian Patent Application No. 2002245655, Dec. 13, 2005. |
APO Notice of Allowance, Australian Patent Application No. 2002245655, Jul. 26, 2006. |
CIPO Office Action, Canadian Patent Application No. 2,643,398, May 5, 2009. |
CIPO Office Action, Canadian Patent Application No. 2,442,176, May 15, 2007. |
CIPO Office Action, Canadian Patent Application No. 2,442,176, Jan. 10, 2008. |
CIPO Office Action, Canadian Patent Application No. 2,442,176, Mar. 10, 2008. |
EPO Office Action, European Patent Application No. 02 713 827.0, Feb. 21, 2005. |
EPO Search Report , European Patent Application No. 06 12 0851.8, May 15, 2007. |
EPO Search Report , European Patent Application No. 08161326.7, Oct. 1, 2008. |
EPO Rule 71(3) Communication, European Patent Application No. 08161326.7, Jul. 20, 2009. |
APO Notice of Allowance, Australian Patent Application No. 2006235930, Feb. 26, 2009. |
CIPO Notice of Allowance, Canadian Patent Application No. 2,442,176, Oct. 24, 2008. |
EPO Rule 51(4) Communication, European Patent Application No. 02713827.0, Feb. 10, 2006. |
EPO Rule 97(2) Communication, European Patent Application No. 02713827.0, Aug. 24, 2006. |
EPO Rule 71(3) Communication, European Patent Application No. 06120851.8, Jul. 14, 2008. |
Complaint, Gen-Probe Incorporated v. Becton Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Oct. 19, 2009. |
Answer and Counterclaim, Gen-Probe Incorporated v. Becton Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Dec. 9, 2009. |
Notice of Opposition to European Patent No. EP 1 795 263 by Becton, Dickinson and Company, European Patent Office, Nov. 26, 2009. |
Brief in Support of Notice of Opposition to European Patent No. EP 1 795 263 by Becton, Dickinson and Company, European Patent Office, Nov. 18, 2009. |
Notice of Opposition to European Patent No. EP 1 795 263 by Sandra Germann, European Patent Office, Nov. 26, 2009. |
Brief in Support of Notice of Opposition to European Patent No. EP 1 795 263 by Sandra Germann, European Patent Office, Nov. 18, 2009. |
English translation of Brief in Support of Notice of Opposition to European Patent No. EP 1 795 263 by Sandra Germann, European Patent Office, Nov. 18, 2009. |
USPTO Office Action, U.S. Appl. No. 11/869,233, Apr. 7, 2009. |
USPTO Office Action, U.S. Appl. No. 12/337,529, May 26, 2009. |
USPTO Interview Summary, U.S. Appl. No. 12/337,529, Dec. 18, 2009. |
CIPO Notice of Allowance, Canadian Patent Application No. 2,643,398, Jan. 11, 2010. |
USPTO Office Action, U.S. Appl. No. 11/869,233, Jul. 2, 2008. |
USPTO Interview Summary, U.S. Appl. No. 11/869,233, Sep. 2, 2009. |
USPTO Interview Summary, U.S. Appl. No. 11/869,233, Sep. 9, 2009. |
USPTO Notice of Allowance, U.S. Appl. No. 11/869,233, Dec. 16, 2009. |
USPTO Office Action, U.S. Appl. No. 12/412,074, Jan. 21, 2010. |
USPTO Office Action, U.S. Appl. No. 12/753,010, Jun. 1, 2010. |
USPTO Office Action, U.S. Appl. No. 12/753,010, Oct. 20, 2010. |
USPTO Notice of Allowance, U.S. Appl. No. 12/753,010, Nov. 1, 2010. |
EPO Rule 97(1) Communication, European Patent Application No. 06120851.8, Jan. 22, 2009. |
Defendant Becton, Dickinson and Company's Patent L.R. 3.3 Preliminary Invalidity Contentions (with Exhibits A-H), Gen-Probe Incorporated v. Becton Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Jun. 11, 2010. |
Defendant Becton, Dickinson and Company's Supplemental Preliminary Invalidity Contentions, Gen-Probe Incorporated v. Becton Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Aug. 2, 2010. |
Proprietor's Observations Relating to Oppositions Filed in Respect of EP 1 795 263, European Patent Office, Sep. 2, 2010. |
USPTO Notice of Allowance, U.S. Appl. No. 12/412,074, Sep. 22, 2010. |
USPTO Notice of Allowance, U.S. Appl. No. 12/753,010, Aug. 29, 2011. |
USPTO Final Office Action, U.S. Appl. No. 12/753,010, Jul. 26, 2011. |
USPTO Office Action, U.S. Appl. No. 12/753,010, Dec. 14, 2010. |
Notice of Opposition to European Patent No. EP 1 990 092 by Becton, Dickinson and Company, European Patent Office, Nov. 16, 2010. |
Notice of Opposition to European Patent No. EP 1 990 092 by Roche Diagnostics Ltd., European Patent Office, Nov. 9, 2010. |
Summons to Attend Oral Proceedings, European Patent No. EP 1 990 092, European Patent Office, Sep. 21, 2011. |
Summons to Attend Oral Proceedings, European Patent No. EP 1 795 263, European Patent Office, Sep. 21, 2011. |
Defendant Becton, Dickinson and Company's Patent L.R. 3.3 Amended Preliminary Invalidity Contentions, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Jun. 17, 2010. |
Becton, Dickinson and Company's Opening Claim Construction Brief (Exhibits 5-7, 8-16, 17-27 and 48-54 only), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Nov. 24, 2010. |
Notice of Lodgment of Exhibits in Support of Gen-Probe Incorporated's Responsive Claim Construction Brief, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Dec. 8, 2010. |
Transcript of Claim Construction Hearing, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, May 3, 2011. |
Plaintiff Gen-Probe Incorporated's Opening Claim Construction Brief (Exhibits 6, 7, 22, 23, 26-32, 41 and 42 only), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Nov. 24, 2010. |
Plaintiff Gen-Probe Incorporated's Responsive Claim Construction Brief (Public Version), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Dec. 8, 2010. |
Joint Claim Construction Chart Pursuant to Patent Local Rule 4.2.A, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Oct. 8, 2010. |
Joint Claim Construction Worksheet Pursuant to Patent Local Rule 4.2.B, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Oct. 8, 2010. |
First Amended Complaint for Patent Infringement, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Apr. 22, 2011. |
Answer and Counterclaim of Defendant Becton, Dickinson and Company to First Amended Complaint, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, May 9, 2011. |
Gen-Probe Incorporated's Reply to Counterclaim of Becton, Dickinson and Company to First Amended Complaint, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, May 19, 2011. |
Gen-Probe Incorporated's Responses and Objections to Defendant Becton, Dickinson and Company's First Set of Interrogatories (Redacted), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Jun. 4, 2010. |
Gen-Probe Incorporated's Responses and Objections to Defendant Becton, Dickinson and Company's Third Set of Interrogatories (Redacted/Exhibit A Excluded), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Dec. 6, 2010. |
Gen-Probe Incorporated's Amended Response and Objections to Defendant Becton, Dickinson and Company's Interrogatory No. 1, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Aug. 27, 2010. |
Gen-Probe Incorporated's Amended Responses and Objections to Defendant Becton, Dickinson and Company's Interrogatory Nos. 2 and 3 (Redacted), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319, United States District Court for the Southern District of California, Nov. 8, 2010. |
Proprietor's Observations Relating to Oppositions Filed in Respect of EP 1 990 092, European Patent Office, Apr. 21, 2011. |
APO Notice of Allowance, Australian Patent Application No. 2009200876, Sep. 11, 2009. |
Amended Claim Construction Order, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319 BEN (NLS), United States District Court for the Southern District of California, Nov. 22, 2011. |
Becton, Dickinson and Company's Final Invalidity Contentions Pursuant to Patent Local Rule 3.6, (Exhibits A-D Included), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, Mar. 15, 2012. |
Becton, Dickinson and Company's Memorandum of Points and Authorities in Support of Motion for Summary Judgment of Invalidity of Asserted '308 Patent Claims (Redacted), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, May 21, 2012. |
Becton, Dickinson and Company's Statement of Undisputed Material Facts in Support of Motion for Summary Judgment of Invalidity of Asserted '308 Patent Claims (Redacted), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, May 21, 2012. |
Declaration of Chris Scott, Ph.D., in Support of Becton, Dickinson and Company's Motion for Summary Judgment of Invalidity of Asserted '308 Patent Claims, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, May 21, 2012. |
Expert Witness Report of Chris Scott, Ph.D., (Redacted) (Appendices A-D Included), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 and 10 CV 0602, United States District Court for the Southern District of California, May 7, 2012. |
Declaration of Barbara A. Fiacco in Support of Becton, Dickinson and Company's Motion for Summary Judgment of Invalidity of Asserted '308 Patent Claims, (Exhibits A-O Included), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, May 21, 2012. |
Rebuttal Expert Report of Michael Jobin Regarding Validity of U.S. Patent Nos. 6,893,612 and 7,294,308 (Redacted), (Appendix E Excluded), Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, May 29, 2012. |
Summary Judgment Order, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action No. 09 CV 2319 BEN (NLS), United States District Court for the Southern District of California, Sep. 28, 2012. |
Order Granting Joint Motion to Dismiss, Gen-Probe Incorporated v. Becton, Dickinson and Company, Civil Action Nos. 09 CV 2319 BEN (NLS) and 10 CV 0602 BEN (NLS), United States District Court for the Southern District of California, Dec. 3, 2012. |
Gen-Probe Incorporated Submissions under Rule 116 EPC, Opposition to European Patent No. EP 1 990 092, European Patent Office, Sep. 14, 2012. |
Becton, Dickinson and Company Submissions Under Rule 116 EPC, Opposition to European Patent No. EP 1 990 092, European Patent Office, Sep. 14, 2012. |
Roche Diagnostics, Ltd., Response, Opposition to European Patent No. EP 1 990 092, European Patent Office, May 16, 2012. |
European Patent Office, Decision Revoking European Patent No. 1 990 092, European Patent Office, Nov. 23, 2012. |
Gen-Probe Incorporated Submissions Under Rule 116 EPC, Opposition to European Patent No. EP 1 795 263, European Patent Office, Sep. 18, 2012. |
Sandra Germann Submissions Under Rule 116 EPC, Opposition to European Patent No. EP 1 795 263, European Patent Office, Sep. 18, 2012. |
Becton, Dickinson and Company Submissions Under Rule 116 EPC, Opposition to European Patent No. EP 1 795 263, European Patent Office, Sep. 18, 2012. |
Minutes of the Oral Proceedings Before the Opposition Division, European Patent No. 1 795 263, European Patent Office, Nov. 11, 2012. |
Decision, European Patent No. 1 795 263, European Patent Office, Oct. 19, 2012. |
USPTO Office Action, U.S. Appl. No. 13/297,136, Apr. 22, 2013. |
USPTO Examiner's Interview Summary, U.S. Appl. No. 13/297,136, Oct. 25, 2013. |
Number | Date | Country | |
---|---|---|---|
60274493 | Mar 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10093511 | Mar 2002 | US |
Child | 10954578 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12753010 | Apr 2010 | US |
Child | 12959016 | US | |
Parent | 11869233 | Oct 2007 | US |
Child | 12753010 | US | |
Parent | 10954578 | Sep 2004 | US |
Child | 11869233 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12959016 | Dec 2010 | US |
Child | 14076031 | US |